Addressing Heavy Alcohol Use Consumption With Kudzu
Public ClinicalTrials.gov record NCT03709043. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A-HACK Project: Addressing Heavy Alcohol Use Consumption With Kudzu
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Drinking multiple alcoholic drinks on a single occasion (binge drinking), has many negative health risks but interventions to address this behavior remain limited. This double-blind, placebo-controlled randomized clinical trial will test whether kudzu, an herbal supplement, can reduce heavy alcohol use and alcohol-associated sexual behaviors among sexually-active, binge-drinking individuals at high risk for HIV infection.
Study identification
- NCT ID
- NCT03709043
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 120 participants
Conditions and interventions
Interventions
- Standardized kudzu Drug
- Placebo Other
- Sexually transmitted infection testing: Diagnostic Test
- Medical Management (MM) counseling for alcohol use: Behavioral
- Urinalysis for novel alcohol biochemical markers for recent alcohol use: Diagnostic Test
- Dried Blood Spot (DBS) Testing for PEth: Diagnostic Test
- Behavioral survey measurements: Behavioral
- Ecological Momentary Assessment procedure: Behavioral
Drug · Other · Diagnostic Test + 1 more
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 10, 2019
- Primary completion
- Mar 31, 2024
- Completion
- May 31, 2024
- Last update posted
- Apr 30, 2026
2019 – 2024
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| San Francisco Department of Public Health | San Francisco | California | 94102 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03709043, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 30, 2026 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03709043 live on ClinicalTrials.gov.